Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Pleural Effusion Induced by Systemic Consumption of Topical Minoxidil: A Rare Case Report

Author(s): Sri Hari Tanguturi Yella, Kistigari Satyanarayana Pramod Kumar, Sree Sudha Tanguturi Yella*, Ruuzeno Kuotsu, Kota Sesha Brahma Sree Krishna Sasanka and Pugazhenthan Thangaraju

Volume 18, Issue 4, 2023

Published on: 31 August, 2022

Page: [589 - 591] Pages: 3

DOI: 10.2174/1574886317666220608154448

Price: $65

Abstract

Introduction: Pleural effusions can be caused by several conditions such as cancer, connective tissue disease, and infection. They are occasionally caused due to the adverse drug reaction. Most commonly, systemic minoxidil use can cause pleural effusions in patients with chronic kidney disease.

Case Presentation: We present a case of a patient without chronic kidney disease who developed pleural effusion as a result of unintentional use of topical minoxidil orally. The patient's oxygen saturation was 90% on room air; there was dullness to percussion and asymmetrical chest expansion with diminished air entry on both sides. In chest x-ray there were bilateral pleural opacities. Minimal pleural effusions were shown in ultrasonography of the chest. The patient was managed with diuretics and airway management which resolved completely.

Conclusion: Minoxidil is a commonly used drug by many people for the treatment of hair fall with or without doctor advice. We would like to stress that even though rare, physicians/pulmonologists should be aware of the rare side effects of topical minoxidil, and it should be kept in mind as a differential diagnosis for pleural effusion.

Keywords: Topical Minoxidil, Pleural effusion, oral infusion, non-kidney disease, Patient, topical solutions

« Previous Next »
[1]
Campese VM. Minoxidil: A review of its pharmacological properties and therapeutic use. Drugs 1981; 22(4): 257-78.
[http://dx.doi.org/10.2165/00003495-198122040-00001] [PMID: 7030707]
[2]
Martin WB, Spodick DH, Zins GR. Pericardial disorders occurring during open-label study of 1,869 severely hypertensive patients treated with minoxidil. J Cardiovasc Pharmacol 1980; 2 (Suppl. 2): S217-27.
[http://dx.doi.org/10.1097/00005344-198000022-00016] [PMID: 6156358]
[3]
Brondfield M, Wu L, Benowitz N. Minoxidil-associated pleuropericardial effusion. J Gen Intern Med 2016; 31(9): 1105.
[http://dx.doi.org/10.1007/s11606-016-3624-3] [PMID: 26951281]
[4]
Kimura T, Doi K. The effect of topical minoxidil treatment on hair follicular growth of neonatal hairless descendants of Mexican hairless dogs. Vet Dermatol 1997; 8(2): 107-13.
[http://dx.doi.org/10.1046/j.1365-3164.1997.d01-7.x] [PMID: 34645063]
[5]
Toll LL, Hurlbut KM, Eds. POISINDEXs System MICROMEDEX. (edition expires 12/2002).
[6]
Farrell SE, Epstein SK. Overdose of rogaines extra strength for men topical minoxidil preparation. J Toxicol Clin Toxicol 1999; 37(6): 781-3.
[http://dx.doi.org/10.1081/CLT-100102457] [PMID: 10584592]
[7]
Sica DA. Minoxidil: An underused vasodilator for resistant or severe hypertension. J Clin Hypertens 2004; 6(5): 283-7.
[http://dx.doi.org/10.1111/j.1524-6175.2004.03585.x] [PMID: 15133413]
[8]
Loniten (minoxidil) 2015. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018154s026lbl.pdf (Accessed on May 24, 2022).
[9]
Siddiqui A, Ansari M, Shakil J, Chemitiganti R. Minoxidil-associated exudative pleural effusion. South Med J 2010; 103(5): 458-60.
[http://dx.doi.org/10.1097/SMJ.0b013e3181be3415] [PMID: 20375958]
[10]
Webb DB, Whale RJ. Pleuropericardial effusion associated with minoxidil administration. Postgrad Med J 1982; 58(679): 319-20.
[http://dx.doi.org/10.1136/pgmj.58.679.319] [PMID: 7111124]
[11]
Palomar R, Morales P, Sanz de Castro S, et al. Pleural effusion secondary to minoxidil in a peritoneal dialysis patient. Nephrol Dial Transplant 2004; 19(10): 2688.
[http://dx.doi.org/10.1093/ndt/gfh444] [PMID: 15388844]
[12]
Hudler A, Ragland MF, Sippe J. Eosinophilic pleural effusion due to topical minoxidil use. In D42. Pleural Disease Case Reports II. American Thoracic Society 2019; pp. A6424-4.
[13]
Farrell SE, Epstein SK. Overdose of rogaine extra strength for men topical minoxidil preparation. J Toxicol Clin Toxicol 1999; 37(6): 781-3.
[http://dx.doi.org/10.1081/CLT-100102457] [PMID: 10584592]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy